
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Most Astonishing Arising Advancements to Watch - 2
Manual for Financial plan Agreeable PC - 3
Famous Kitchen Finishing Styles For 2024 - 4
NASA just launched Artemis 2. What happens today could make or break the moon mission - 5
2026 Golden Globes live updates: Red carpet arrivals will kick off the night; Nikki Glaser set to host
Judge approves Purdue Pharma’s new $7B opioid settlement with the Sacklers
Magnetic fossils may reveal ancient creature's internal 'GPS system'
Palestine weekly wrap: Protests sweep West Bank after death penalty law
6 Trail blazing Bicycles for Rough terrain Undertakings
Eight wounded, cars catch fire in central Israel following strike from Iranian cluster munition
These HGTV stars made a pledge to keep their kids off smartphones. Here's how it's going.
Giant ‘toothed’ birds flew over Antarctica 40 million to 50 million years ago
Turning into a Distributed Writer: My Composing Process
EU chief urges Iran to free imprisoned protesters, lift internet ban













